Real-World Effectiveness and Safety of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: A Multicenter Study From Spain


Por: Armario-Hita, JC, Galán-Gutierrez, M, Pereyra-Rodríguez, JJ, Suarez-Pérez, J, Rodríguez-Serna, M, de Frutos, JO, Carrascosa, JM, Serra-Baldrich, E, Figueras-Nar, I, Zaragoza-Ninet, V and Ruiz-Villaverde, R

Publicada: 1 jun 2026 Ahead of Print: 1 nov 2025
Resumen:


Filiaciones:
Armario-Hita, JC:
 Univ Cadiz, Hosp Univ Puerto Real, Dept Dermatol, Puerto Real, Spain

Galán-Gutierrez, M:
 Hosp Univ Reina Sofia, Dept Dermatol, Cordoba, Spain

Pereyra-Rodríguez, JJ:
 Hosp Univ Virgen Rocio, Seville, Spain

 Univ Seville, Sch Med, Dept Med, Seville, Spain

Suarez-Pérez, J:
 Hosp Univ Virgen Victoria, Dept Dermatol, Malaga, Spain

Rodríguez-Serna, M:
 Hosp Univ La Fe, Dept Dermatol, Valencia, Spain

de Frutos, JO:
 Hosp Univ 12 Octubre, Dept Dermatol, Madrid, Spain

:
 Hosp Univ Germans Trias I Pujol, Dept Dermatol, Badalona, Spain

Serra-Baldrich, E:
 Hosp Univ San Pau, Dept Dermatol, Barcelona, Spain

Figueras-Nar, I:
 Hosp Univ Bellvitge, Dept Dermatol, Barcelona, Spain

Zaragoza-Ninet, V:
 Hosp Gen Univ Valencia, Dept Dermatol, Valencia, Spain

Ruiz-Villaverde, R:
 Hosp Univ San Cecilio, Dept Dermatol, Granada, Spain
ISSN: 13654632





International Journal of Dermatology
Editorial
Blackwell Publishing Inc., 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Reino Unido
Tipo de documento: Editorial Material
Volumen: 65 Número: 6
Páginas: 1253-1255
WOS Id: 001626880900001
ID de PubMed: 41310412
imagen Bronze

MÉTRICAS